| Dr John Mark Snyder, OD | |
|
1945 Queenswood Drive, York, PA 17403-4254 | |
| (717) 846-6900 | |
| (717) 854-9728 |
| Full Name | Dr John Mark Snyder |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 17 Years |
| Location | 1945 Queenswood Drive, York, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003016304 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | OEG001953 (Pennsylvania) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ophthalmology Associates Of York, Llp | 1658350707 | 2 |
News Archive
Every year, nearly 2 million people on Medicare — most of them older adults — go to a skilled nursing facility to recover after a hospitalization. But choosing the facility can be daunting, according to an emerging body of research.
Researchers at Mount Sinai School of Medicine have found that the costs of care for patients with cancer who disenrolled from hospice were nearly five times higher than for patients who remained with hospice. Patients who disenroll from hospice are far more likely to use emergency department care and be hospitalized. The results are published in the October 1 issue of the Journal of Clinical Oncology.
GE Capital's Healthcare Financial Services business has provided a $9 million term loan to Cerapedics, Inc., a privately-held medical device company based in Westminster, CO. The funds will be used to support Cerapedics' general business operations, including the advancement of its U.S. regulatory process.
A multi-institutional, Phase II study led by The University of Texas MD Anderson Cancer Center showed that pairing standard chemotherapy azacitidine (AZA) with a drug called enasidenib (ENA) measurably boosts complete remission in patients newly diagnosed with a specific form of acute myeloid leukemia (AML).
Thirteen scientists received a total of $1.05 million in funding from the National Psoriasis Foundation for projects that aim to identify new treatments and a cure for psoriasis—an autoimmune disease that appears on the skin, affecting 7.5 million Americans—and psoriatic arthritis—an inflammatory arthritis that affects the joints and tendons, occurring in up to 30 percent of people with psoriasis.
› Verified 3 days ago
| Provider Name | Salus University |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1336160027 PECOS PAC ID: 9133031883 Enrollment ID: O20040302000032 |
News Archive
Every year, nearly 2 million people on Medicare — most of them older adults — go to a skilled nursing facility to recover after a hospitalization. But choosing the facility can be daunting, according to an emerging body of research.
Researchers at Mount Sinai School of Medicine have found that the costs of care for patients with cancer who disenrolled from hospice were nearly five times higher than for patients who remained with hospice. Patients who disenroll from hospice are far more likely to use emergency department care and be hospitalized. The results are published in the October 1 issue of the Journal of Clinical Oncology.
GE Capital's Healthcare Financial Services business has provided a $9 million term loan to Cerapedics, Inc., a privately-held medical device company based in Westminster, CO. The funds will be used to support Cerapedics' general business operations, including the advancement of its U.S. regulatory process.
A multi-institutional, Phase II study led by The University of Texas MD Anderson Cancer Center showed that pairing standard chemotherapy azacitidine (AZA) with a drug called enasidenib (ENA) measurably boosts complete remission in patients newly diagnosed with a specific form of acute myeloid leukemia (AML).
Thirteen scientists received a total of $1.05 million in funding from the National Psoriasis Foundation for projects that aim to identify new treatments and a cure for psoriasis—an autoimmune disease that appears on the skin, affecting 7.5 million Americans—and psoriatic arthritis—an inflammatory arthritis that affects the joints and tendons, occurring in up to 30 percent of people with psoriasis.
› Verified 3 days ago
| Provider Name | Ophthalmology Associates Of York, Llp |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1912933318 PECOS PAC ID: 1658350707 Enrollment ID: O20040714000534 |
News Archive
Every year, nearly 2 million people on Medicare — most of them older adults — go to a skilled nursing facility to recover after a hospitalization. But choosing the facility can be daunting, according to an emerging body of research.
Researchers at Mount Sinai School of Medicine have found that the costs of care for patients with cancer who disenrolled from hospice were nearly five times higher than for patients who remained with hospice. Patients who disenroll from hospice are far more likely to use emergency department care and be hospitalized. The results are published in the October 1 issue of the Journal of Clinical Oncology.
GE Capital's Healthcare Financial Services business has provided a $9 million term loan to Cerapedics, Inc., a privately-held medical device company based in Westminster, CO. The funds will be used to support Cerapedics' general business operations, including the advancement of its U.S. regulatory process.
A multi-institutional, Phase II study led by The University of Texas MD Anderson Cancer Center showed that pairing standard chemotherapy azacitidine (AZA) with a drug called enasidenib (ENA) measurably boosts complete remission in patients newly diagnosed with a specific form of acute myeloid leukemia (AML).
Thirteen scientists received a total of $1.05 million in funding from the National Psoriasis Foundation for projects that aim to identify new treatments and a cure for psoriasis—an autoimmune disease that appears on the skin, affecting 7.5 million Americans—and psoriatic arthritis—an inflammatory arthritis that affects the joints and tendons, occurring in up to 30 percent of people with psoriasis.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John Mark Snyder, OD 1945 Queenswood Drive, York, PA 17403-4254 Ph: (717) 846-6900 | Dr John Mark Snyder, OD 1945 Queenswood Drive, York, PA 17403-4254 Ph: (717) 846-6900 |
News Archive
Every year, nearly 2 million people on Medicare — most of them older adults — go to a skilled nursing facility to recover after a hospitalization. But choosing the facility can be daunting, according to an emerging body of research.
Researchers at Mount Sinai School of Medicine have found that the costs of care for patients with cancer who disenrolled from hospice were nearly five times higher than for patients who remained with hospice. Patients who disenroll from hospice are far more likely to use emergency department care and be hospitalized. The results are published in the October 1 issue of the Journal of Clinical Oncology.
GE Capital's Healthcare Financial Services business has provided a $9 million term loan to Cerapedics, Inc., a privately-held medical device company based in Westminster, CO. The funds will be used to support Cerapedics' general business operations, including the advancement of its U.S. regulatory process.
A multi-institutional, Phase II study led by The University of Texas MD Anderson Cancer Center showed that pairing standard chemotherapy azacitidine (AZA) with a drug called enasidenib (ENA) measurably boosts complete remission in patients newly diagnosed with a specific form of acute myeloid leukemia (AML).
Thirteen scientists received a total of $1.05 million in funding from the National Psoriasis Foundation for projects that aim to identify new treatments and a cure for psoriasis—an autoimmune disease that appears on the skin, affecting 7.5 million Americans—and psoriatic arthritis—an inflammatory arthritis that affects the joints and tendons, occurring in up to 30 percent of people with psoriasis.
› Verified 3 days ago
Dr. Matthew J Link, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 25 Monument Rd, Suite 297, York, PA 17403 Phone: 717-741-6732 Fax: 717-741-6058 | |
Dr. James P. Tuttle And Associates Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2050 E Market St, York, PA 17402 Phone: 717-755-6906 Fax: 717-840-4847 | |
Mrs. Colleen Mary Rae-jenkins, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 25 Monument Rd Ste 297, York, PA 17403 Phone: 717-741-6732 Fax: 717-741-6058 | |
Myeyedr. Optometrist Medicare: Medicare Enrolled Practice Location: 2553 E Market St, York, PA 17402 Phone: 717-757-5632 | |
Eyecare Professionals Optometrist Medicare: Not Enrolled in Medicare Practice Location: 855 N Adams St, York, PA 17404 Phone: 717-843-8993 Fax: 717-848-5217 | |
Dr. Erika Elizabeth Mabus, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 25 Monument Rd, #297, York, PA 17403 Phone: 717-741-6732 |